Related Experiment Video
Updated: Jun 17, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Pharmacists' role in improving diabetes medication management
1University of Connecticut School of Pharmacy, 69 N. Eagleville Rd., Unit 3092, Storrs, CT 06269-3092, USA. marie.smith@uconn.edu
Journal of Diabetes Science and Technology
|January 5, 2010
Summary
Pharmacist-led diabetes programs bridge the gap to optimal medication therapy. These initiatives improve patient outcomes and empower individuals in managing their health effectively.
Area of Science:
- Pharmacy Practice
- Pharmacotherapy
- Patient Care
Background:
- Significant disparities exist between ideal and actual medication therapy outcomes in the U.S.
- Pharmacists are underutilized healthcare professionals with the potential to improve medication therapy outcomes.
- The
- medical home
- model emphasizes collaborative, patient-centered care.
Purpose of the Study:
- To describe pharmacist-led diabetes medication management programs.
- To highlight the role of pharmacists in achieving optimal medication therapy.
- To underscore the integration of pharmacists within a collaborative care model.
Main Methods:
- Review and description of existing pharmacist-led diabetes medication management programs.
- Emphasis on the application of clinical expertise in monitoring and managing diabetes medications.
- Exploration of pharmacist's role as a resource for other healthcare providers and payers.
Main Results:
- Pharmacist-led programs demonstrate a positive impact on patient health outcomes.
- Patients are empowered to actively participate in managing their diabetes.
- Pharmacists contribute to safe, appropriate, and cost-effective diabetes medication use.
Conclusions:
- Pharmacist-led interventions are crucial for advancing optimal medication therapy.
- Integrating pharmacists into care models enhances patient-centered diabetes management.
- Pharmacists play a vital role in optimizing medication use and improving health outcomes.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...